D Topolsky Selected Research

Non-Hodgkin Lymphoma (Lymphosarcoma)

2/2001

Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation: what is the optimal timing?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D Topolsky Research Topics

Disease

1	Breast Neoplasms (Breast Cancer) 02/2001
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2001
1	Hemolytic Anemia 01/2001
1	Thrombotic Thrombocytopenic Purpura 01/2001
1	Thrombocytopenia (Thrombopenia) 01/2001
1	Blast Crisis (Blast Phase) 08/2000
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2000
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2000

Drug/Important Bio-Agent (IBA)

1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2001
1	thiamine triphosphorate (TTP)IBA 01/2001
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2001
1	Methotrexate (Mexate)FDA LinkGeneric 08/2000
1	Interferon-alpha (Interferon Alfa)IBA 08/2000

Therapy/Procedure

2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2001 - 01/2001
2	Drug Therapy (Chemotherapy) 02/2001 - 08/2000
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 02/2001
1	Plasma Exchange 01/2001
1	Therapeutics 08/2000
1	Stem Cell Transplantation 01/2000